The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Regulatory News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 344.00
Bid: 344.00
Ask: 346.00
Change: -6.00 (-1.71%)
Spread: 2.00 (0.581%)
Open: 346.00
High: 349.00
Low: 343.00
Prev. Close: 350.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NOTIFICATION OF MAJOR HOLDINGS

1 Nov 2017 09:45

RNS Number : 2399V
Hutchison China Meditech Limited
01 November 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Hutchison China MediTech Limited;

Legal Entity Identifier: 2138006X34YDQ6OBYE79

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Voluntary disclosure

X

3. Details of person subject to the notification obligationiv

Name

Hutchison Healthcare Holdings Limited

City and country of registered office (if applicable)

British Virgin Islands

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

30/10/2017

6. Date on which issuer notified (DD/MM/YYYY):

30/10/2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

60.36%

60.36%

66,435,037

Position of previous notification (if

applicable)

60.36%

60.36%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares (KYG4672N1016) and American Depositary Shares (US44842L1035)

40,097,877

60.36%

SUBTOTAL 8. A

40,097,877

60.36%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

CK Hutchison Holdings Limited - indirect, but ultimate, owner of the shareholder

60.36%

60.36%

Hutchison Whampoa (China) Limited - direct owner of the shareholder and a subsidiary of CK Hutchison Holdings Limited

60.36%

60.36%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Voluntary notification following an offering of American Depository Shares by Hutchison China MediTech Limited.

 

Place of completion

Hong Kong

Date of completion

31 October 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBBBLTMBJMMFR
Date   Source Headline
13th May 20157:00 amRNSFruquintinib results trigger payments from Lilly
30th Apr 20157:00 amRNSTotal Voting Rights
24th Apr 201512:40 pmRNSResult of AGM
22nd Apr 201511:23 amRNSDirector/PDMR Shareholding
16th Apr 20151:19 pmRNSDirector's Shareholding
13th Apr 20158:07 amRNSDirector's Shareholding
8th Apr 20158:18 amRNSDirectors' Shareholding
1st Apr 20153:48 pmRNSDirectors Shareholding
1st Apr 20152:32 pmRNSExercise of Options
30th Mar 20157:00 amRNSTrial of fruquintinib achieves primary endpoint
23rd Mar 20157:00 amRNSNotice of AGM
18th Mar 20157:08 amRNSNotification of Major Interest in Shares
6th Mar 20157:06 amRNSPatient enrolment completion for Phase II study
26th Feb 20157:00 amRNSFinal Results
29th Jan 20157:00 amRNSDistribution Agreement for Seroquel in China
26th Jan 20157:00 amRNSNotice of Results
31st Dec 20147:00 amRNSTotal Voting Rights
29th Dec 20147:00 amRNSBlocklisting Six Monthly Return
15th Dec 20147:00 amRNSInitiation of fruquintinib Phase III study
31st Oct 20147:03 amRNSTotal Voting Rights
7th Oct 20147:00 amRNSDrug R&D Update Briefing
1st Oct 20147:00 amRNSCo-promotion agreement with Merck Serono
19th Sep 20149:13 amRNSHolding(s) in Company
21st Aug 20147:00 amRNSPatient enrolment in Phase II study completed
13th Aug 20147:00 amRNSHMPL-004 Interim Analysis
29th Jul 20147:00 amRNSInterim Results
30th Jun 20147:00 amRNSBlocklisting Interim Review
30th Jun 20147:00 amRNSTotal Voting Rights
26th Jun 20147:00 amRNSNotice of Results
25th Jun 20147:00 amRNSChi-Med Refinancing of Existing Loan Facility
18th Jun 20147:00 amRNSStart of Phase I clinical trial with HMPL-523
5th Jun 20147:00 amRNSInitiation of fruquintinib Phase II study
4th Jun 20141:52 pmRNSDirector's Shareholding
3rd Jun 20143:23 pmRNSExercise of Options
30th May 20149:10 amRNSGains rights to six prescription drug products
23rd May 20147:00 amRNSInitiation of Phase II Study in Renal Cancer
22nd May 20147:00 amRNSPhase I data to be presented at ASCO
8th May 201411:54 amRNSResult of AGM
17th Apr 20147:00 amRNSChi-Med and Sinopharm Deal Approved
4th Apr 20147:00 amRNSInitiation of Phase II study in colorectal cancer
4th Apr 20147:00 amRNSPresentations at the 2014 AACR Annual Meeting
28th Mar 20147:00 amRNS2013 Annual Report and Notice of AGM
18th Feb 20147:00 amRNSFinal Results
13th Feb 20148:14 amRNSNotification of Major Interest in Shares
16th Jan 20147:00 amRNSNotice of Results
30th Dec 20137:00 amRNSBlocklisting Six Monthly Return
18th Dec 20139:02 amRNSSinopharm distribution joint venture in China
16th Oct 201311:58 amRNSDirector/PDMR Shareholding
9th Oct 20137:00 amRNSPayment From Janssen Pharmaceuticals
9th Oct 20137:00 amRNSLilly Deal for Fruquintinib

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.